Cargando…
Warfarin versus direct oral anticoagulants for treating left ventricular thrombus: a systematic review and meta-analysis
BACKGROUND: Left ventricular thrombus (LVT) is not uncommon and pose a risk of systemic embolism, which can be mitigated by adequate anticoagulation. Direct oral anticoagulants (DOACs) are increasingly being used as alternatives to warfarin for anticoagulation, but their efficacy and safety profile...
Autores principales: | Dalia, Tarun, Lahan, Shubham, Ranka, Sagar, Goyal, Amandeep, Zoubek, Sara, Gupta, Kamal, Shah, Zubair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849079/ https://www.ncbi.nlm.nih.gov/pubmed/33517885 http://dx.doi.org/10.1186/s12959-021-00259-w |
Ejemplares similares
-
Direct oral anticoagulant use in left ventricular thrombus
por: Ali, Zafar, et al.
Publicado: (2020) -
Impact of congestive heart failure and role of cardiac biomarkers in COVID-19 patients: A systematic review and meta-analysis
por: Dalia, Tarun, et al.
Publicado: (2021) -
Transcatheter aortic valve replacement for aortic insufficiency in a patient with aortic root Thrombus and left ventricular assist device: A risk worth taking?
por: Malhotra, Anureet, et al.
Publicado: (2023) -
Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus
por: Iqbal, Hansa, et al.
Publicado: (2020) -
Direct Oral Anticoagulants for Stroke and Systemic Embolism Prevention in Patients with Left Ventricular Thrombus
por: Badescu, Minerva Codruta, et al.
Publicado: (2023)